Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 9/2016

Content (10 Articles)

Open Access Review

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

Christoph Hoeller, Olivier Michielin, Paolo A. Ascierto, Zsolt Szabo, Christian U. Blank

Original Article

B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma

Lei Wu, Wei-Wei Deng, Guang-Tao Yu, Liang Mao, Lin-Lin Bu, Si-Rui Ma, Bing Liu, Wen-Feng Zhang, Zhi-Jun Sun

Original Article

Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion

Wei Wang, Amy K. Erbe, Kory A. Alderson, Emily Phillips, Mikayla Gallenberger, Jacek Gan, Dario Campana, Jacquelyn A. Hank, Paul M. Sondel

Original Article

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer

Krista P. Terracina, Laura J. Graham, Kyle K. Payne, Masoud H. Manjili, Annabel Baek, Sheela R. Damle, Harry D. Bear

Original Article

Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice

Abderraouf Selmi, Fulvia Vascotto, Kordula Kautz-Neu, Özlem Türeci, Ugur Sahin, Esther von Stebut, Mustafa Diken, Sebastian Kreiter

Original Article

Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells

Anna K. Kozlowska, Han-Ching Tseng, Kawaljit Kaur, Paytsar Topchyan, Akihito Inagaki, Vickie T. Bui, Noriyuki Kasahara, Nicholas Cacalano, Anahid Jewett

Original Article

Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis

Hidenori Takahashi, Shigetaka Shimodaira, Masahiro Ogasawara, Shuichi Ota, Masanori Kobayashi, Hirofumi Abe, Yuji Morita, Kazuhiro Nagai, Shunichi Tsujitani, Masato Okamoto, Yukio Suzuki, Yoichi Nakanishi, Yoshikazu Yonemitsu

Open Access Original Article

Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

Said Farschtschi, Su-Jin Park, Birgit Sawitzki, Su-Jun Oh, Lan Kluwe, Victor F. Mautner, Andreas Kurtz

Original Article

The immunomodulatory, antitumor and antimetastatic responses of melanoma-bearing normal and alcoholic mice to sunitinib and ALT-803: a combinatorial treatment approach

Kari A. Gaither, Alexander A. Little, Alisha A. McBride, Savanna R. Garcia, Kiranjot K. Brar, Zhaohui Zhu, Amity Platt, Faya Zhang, Gary G. Meadows, Hui Zhang

Original Article

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes

Kristoffer Sand, Jakob Theorell, Øystein Bruserud, Yenan T. Bryceson, Astrid Olsnes Kittang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine